Merck & Co., Inc. (MRK) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - General industria. La empresa tiene su sede en Rahway, NJ, United States. El CEO actual es Robert Davis.
MRK tiene fecha de IPO 1978-01-13, 73,000 empleados a tiempo completo, cotiza en el NYSE, una capitalización de mercado de $296.59B.
Merck & Co., Inc. is a global healthcare company founded in 1891 and headquartered in Kenilworth, New Jersey. Operating through two primary segments—Pharmaceutical and Animal Health—the company develops and markets a diverse portfolio of human health pharmaceuticals spanning oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular disease, and diabetes treatment, along with preventive vaccines for pediatric, adolescent, and adult populations. The Animal Health segment manufactures veterinary pharmaceuticals, vaccines, and health management solutions, complemented by digital products for animal identification and monitoring. Merck distributes its products to drug wholesalers, retailers, hospitals, government agencies, managed care providers, and healthcare professionals worldwide, while maintaining strategic collaborations with leading pharmaceutical companies including AstraZeneca, Bayer, Eisai, Ridgeback Biotherapeutics, and Gilead Sciences to advance long-acting HIV treatments.
